Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Long-term use of canthaxanthin may cause reversible changes in the eye, including crystal deposits and altered vision responses.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Glycine is a key transmitter in rat spinal cord synapses, often alongside GABA.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Aδ-LTMRs have complex synapses with glycine, while Aβ-LTMRs have simpler ones.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Presynaptic inhibition of certain nerve fibers in cats is mainly controlled by GABA and glycine.

Special astrocytes improved learning and memory in rats after a stroke.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

FFA and FAPD might be related or stages of the same disease.

Glycine likely affects dendrites connected to hair follicle terminals in rats.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Forsythiaside A helps reduce brain damage from lack of blood flow by activating certain protective pathways.

FGF-1 causes spiral ganglion neurites to branch more.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Hair-follicle nerves in cats' spinal cords can be inhibited by GABA-related connections.

Giant axonal neuropathy changes the structure of keratin in human hair, making it stiffer and stronger.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Giant axonal neuropathy changes the structure of keratin in human hair.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

The patient's hair had unique damage and a lower sulfur-to-nitrogen ratio compared to relatives, but not compared to healthy controls.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.